Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score:6

RTAnswers

Gynecologic Cancer – RTAnswers.org - 1 week

Mashup Score:6

Treatment for gynecologic cancers depends on several factors, including the type of cancer, its extent (stage), its location and your overall health. It is...

  • 1615756503121526789 Profile photo of Madelyn

    January is Cervical Cancer Awareness Month. According to the American Cancer Society, 115,130 women will be diagnosed with some form of gynecologic cancer this year. Learn how radiation therapy is used to treat gynecologic cancers here: https://t.co/FG1aG3pZgU #gyncsm https://t.co/FG1aG3pZgU - view on twitter

For cervical cancer awareness month, Lauren Bollinger, MD, discusses how the increase in research in the field of cervical cancer is driving the progress...

Dr Robert Holloway describes the presentation of a typical patient with metastatic endometrial cancer, and whether all patients receive MMR...

Saketh Guntupalli, MD, highlights data supporting PARP inhibitors as the standard-of-care frontline therapy, strategies for the management of PARP-related toxicities, and the importance of...

By The ASCO Post Staff Posted: 1/18/2023 12:32:00 PM Last Updated: 1/18/2023 1:06:31 PM A specific colonization of pathogenic microbes in the reproductive tract...

In partnership with Tumor Board Tuesday, this CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly...

By Matthew Stenger Posted: 1/23/2023 10:24:00 AM Last Updated: 1/23/2023 11:31:50 AM In an analysis reported in the Journal of Clinical Oncology, Vicky Makker,...

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma...

Kathleen N. Moore, MD, MS, discusses the investigation of nab-sirolimus in TSC1/2-mutated gynecologic...

The FDA has granted a fast track designation to DB-1303 for the treatment of patients with advanced, recurrent or metastatic endometrial cancer with HER2...